Searching for plant-derived antivirals against dengue virus and Zika virus
Abstract Background The worldwide epidemics of diseases as dengue and Zika have triggered an intense effort to repurpose drugs and search for novel antivirals to treat patients as no approved drugs for these diseases are currently available. Our aim was to screen plant-derived extracts to identify a...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-02-01
|
Series: | Virology Journal |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12985-022-01751-z |
_version_ | 1818982105708756992 |
---|---|
author | Emerson de Castro Barbosa Tânia Maria Almeida Alves Markus Kohlhoff Soraya Torres Gaze Jangola Douglas Eduardo Valente Pires Anna Carolina Cançado Figueiredo Érica Alessandra Rocha Alves Carlos Eduardo Calzavara-Silva Marcos Sobral Erna Geessien Kroon Luiz Henrique Rosa Carlos Leomar Zani Jaquelline Germano de Oliveira |
author_facet | Emerson de Castro Barbosa Tânia Maria Almeida Alves Markus Kohlhoff Soraya Torres Gaze Jangola Douglas Eduardo Valente Pires Anna Carolina Cançado Figueiredo Érica Alessandra Rocha Alves Carlos Eduardo Calzavara-Silva Marcos Sobral Erna Geessien Kroon Luiz Henrique Rosa Carlos Leomar Zani Jaquelline Germano de Oliveira |
author_sort | Emerson de Castro Barbosa |
collection | DOAJ |
description | Abstract Background The worldwide epidemics of diseases as dengue and Zika have triggered an intense effort to repurpose drugs and search for novel antivirals to treat patients as no approved drugs for these diseases are currently available. Our aim was to screen plant-derived extracts to identify and isolate compounds with antiviral properties against dengue virus (DENV) and Zika virus (ZIKV). Methods Seven thousand plant extracts were screened in vitro for their antiviral properties against DENV-2 and ZIKV by their viral cytopathic effect reduction followed by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) method, previously validated for this purpose. Selected extracts were submitted to bioactivity-guided fractionation using high- and ultrahigh-pressure liquid chromatography. In parallel, high-resolution mass spectrometric data (MSn) were collected from each fraction, allowing compounds into the active fractions to be tracked in subsequent fractionation procedures. The virucidal activity of extracts and compounds was assessed by using the plaque reduction assay. EC50 and CC50 were determined by dose response experiments, and the ratio (EC50/CC50) was used as a selectivity index (SI) to measure the antiviral vs. cytotoxic activity. Purified compounds were used in nuclear magnetic resonance spectroscopy to identify their chemical structures. Two compounds were associated in different proportions and submitted to bioassays against both viruses to investigate possible synergy. In silico prediction of the pharmacokinetic and toxicity (ADMET) properties of the antiviral compounds were calculated using the pkCSM platform. Results We detected antiviral activity against DENV-2 and ZIKV in 21 extracts obtained from 15 plant species. Hippeastrum (Amaryllidaceae) was the most represented genus, affording seven active extracts. Bioactivity-guided fractionation of several extracts led to the purification of lycorine, pretazettine, narciclasine, and narciclasine-4-O-β-D-xylopyranoside (NXP). Another 16 compounds were identified in active fractions. Association of lycorine and pretazettine did not improve their antiviral activity against DENV-2 and neither to ZIKV. ADMET prediction suggested that these four compounds may have a good metabolism and no mutagenic toxicity. Predicted oral absorption, distribution, and excretion parameters of lycorine and pretazettine indicate them as candidates to be tested in animal models. Conclusions Our results showed that plant extracts, especially those from the Hippeastrum genus, can be a valuable source of antiviral compounds against ZIKV and DENV-2. The majority of compounds identified have never been previously described for their activity against ZIKV and other viruses. |
first_indexed | 2024-12-20T17:41:56Z |
format | Article |
id | doaj.art-4ca21516290e4a47a15004c79d0ef587 |
institution | Directory Open Access Journal |
issn | 1743-422X |
language | English |
last_indexed | 2024-12-20T17:41:56Z |
publishDate | 2022-02-01 |
publisher | BMC |
record_format | Article |
series | Virology Journal |
spelling | doaj.art-4ca21516290e4a47a15004c79d0ef5872022-12-21T19:31:05ZengBMCVirology Journal1743-422X2022-02-0119111510.1186/s12985-022-01751-zSearching for plant-derived antivirals against dengue virus and Zika virusEmerson de Castro Barbosa0Tânia Maria Almeida Alves1Markus Kohlhoff2Soraya Torres Gaze Jangola3Douglas Eduardo Valente Pires4Anna Carolina Cançado Figueiredo5Érica Alessandra Rocha Alves6Carlos Eduardo Calzavara-Silva7Marcos Sobral8Erna Geessien Kroon9Luiz Henrique Rosa10Carlos Leomar Zani11Jaquelline Germano de Oliveira12Instituto René Rachou - Fiocruz Minas, Fundação Oswaldo CruzInstituto René Rachou - Fiocruz Minas, Fundação Oswaldo CruzInstituto René Rachou - Fiocruz Minas, Fundação Oswaldo CruzInstituto René Rachou - Fiocruz Minas, Fundação Oswaldo CruzInstituto René Rachou - Fiocruz Minas, Fundação Oswaldo CruzInstituto René Rachou - Fiocruz Minas, Fundação Oswaldo CruzInstituto René Rachou - Fiocruz Minas, Fundação Oswaldo CruzInstituto René Rachou - Fiocruz Minas, Fundação Oswaldo CruzDepartamento de Ciências Naturais, Universidade Federal de São João del-ReiDepartamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas GeraisDepartamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas GeraisInstituto René Rachou - Fiocruz Minas, Fundação Oswaldo CruzInstituto René Rachou - Fiocruz Minas, Fundação Oswaldo CruzAbstract Background The worldwide epidemics of diseases as dengue and Zika have triggered an intense effort to repurpose drugs and search for novel antivirals to treat patients as no approved drugs for these diseases are currently available. Our aim was to screen plant-derived extracts to identify and isolate compounds with antiviral properties against dengue virus (DENV) and Zika virus (ZIKV). Methods Seven thousand plant extracts were screened in vitro for their antiviral properties against DENV-2 and ZIKV by their viral cytopathic effect reduction followed by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) method, previously validated for this purpose. Selected extracts were submitted to bioactivity-guided fractionation using high- and ultrahigh-pressure liquid chromatography. In parallel, high-resolution mass spectrometric data (MSn) were collected from each fraction, allowing compounds into the active fractions to be tracked in subsequent fractionation procedures. The virucidal activity of extracts and compounds was assessed by using the plaque reduction assay. EC50 and CC50 were determined by dose response experiments, and the ratio (EC50/CC50) was used as a selectivity index (SI) to measure the antiviral vs. cytotoxic activity. Purified compounds were used in nuclear magnetic resonance spectroscopy to identify their chemical structures. Two compounds were associated in different proportions and submitted to bioassays against both viruses to investigate possible synergy. In silico prediction of the pharmacokinetic and toxicity (ADMET) properties of the antiviral compounds were calculated using the pkCSM platform. Results We detected antiviral activity against DENV-2 and ZIKV in 21 extracts obtained from 15 plant species. Hippeastrum (Amaryllidaceae) was the most represented genus, affording seven active extracts. Bioactivity-guided fractionation of several extracts led to the purification of lycorine, pretazettine, narciclasine, and narciclasine-4-O-β-D-xylopyranoside (NXP). Another 16 compounds were identified in active fractions. Association of lycorine and pretazettine did not improve their antiviral activity against DENV-2 and neither to ZIKV. ADMET prediction suggested that these four compounds may have a good metabolism and no mutagenic toxicity. Predicted oral absorption, distribution, and excretion parameters of lycorine and pretazettine indicate them as candidates to be tested in animal models. Conclusions Our results showed that plant extracts, especially those from the Hippeastrum genus, can be a valuable source of antiviral compounds against ZIKV and DENV-2. The majority of compounds identified have never been previously described for their activity against ZIKV and other viruses.https://doi.org/10.1186/s12985-022-01751-zAntiviralDengue virusZika virusAlkaloidsNatural productsPlant extract |
spellingShingle | Emerson de Castro Barbosa Tânia Maria Almeida Alves Markus Kohlhoff Soraya Torres Gaze Jangola Douglas Eduardo Valente Pires Anna Carolina Cançado Figueiredo Érica Alessandra Rocha Alves Carlos Eduardo Calzavara-Silva Marcos Sobral Erna Geessien Kroon Luiz Henrique Rosa Carlos Leomar Zani Jaquelline Germano de Oliveira Searching for plant-derived antivirals against dengue virus and Zika virus Virology Journal Antiviral Dengue virus Zika virus Alkaloids Natural products Plant extract |
title | Searching for plant-derived antivirals against dengue virus and Zika virus |
title_full | Searching for plant-derived antivirals against dengue virus and Zika virus |
title_fullStr | Searching for plant-derived antivirals against dengue virus and Zika virus |
title_full_unstemmed | Searching for plant-derived antivirals against dengue virus and Zika virus |
title_short | Searching for plant-derived antivirals against dengue virus and Zika virus |
title_sort | searching for plant derived antivirals against dengue virus and zika virus |
topic | Antiviral Dengue virus Zika virus Alkaloids Natural products Plant extract |
url | https://doi.org/10.1186/s12985-022-01751-z |
work_keys_str_mv | AT emersondecastrobarbosa searchingforplantderivedantiviralsagainstdenguevirusandzikavirus AT taniamariaalmeidaalves searchingforplantderivedantiviralsagainstdenguevirusandzikavirus AT markuskohlhoff searchingforplantderivedantiviralsagainstdenguevirusandzikavirus AT sorayatorresgazejangola searchingforplantderivedantiviralsagainstdenguevirusandzikavirus AT douglaseduardovalentepires searchingforplantderivedantiviralsagainstdenguevirusandzikavirus AT annacarolinacancadofigueiredo searchingforplantderivedantiviralsagainstdenguevirusandzikavirus AT ericaalessandrarochaalves searchingforplantderivedantiviralsagainstdenguevirusandzikavirus AT carloseduardocalzavarasilva searchingforplantderivedantiviralsagainstdenguevirusandzikavirus AT marcossobral searchingforplantderivedantiviralsagainstdenguevirusandzikavirus AT ernageessienkroon searchingforplantderivedantiviralsagainstdenguevirusandzikavirus AT luizhenriquerosa searchingforplantderivedantiviralsagainstdenguevirusandzikavirus AT carlosleomarzani searchingforplantderivedantiviralsagainstdenguevirusandzikavirus AT jaquellinegermanodeoliveira searchingforplantderivedantiviralsagainstdenguevirusandzikavirus |